NO20031537L - Nye farmasöytiske blandinger inneholdende epinastin og pseudoefedrin - Google Patents

Nye farmasöytiske blandinger inneholdende epinastin og pseudoefedrin

Info

Publication number
NO20031537L
NO20031537L NO20031537A NO20031537A NO20031537L NO 20031537 L NO20031537 L NO 20031537L NO 20031537 A NO20031537 A NO 20031537A NO 20031537 A NO20031537 A NO 20031537A NO 20031537 L NO20031537 L NO 20031537L
Authority
NO
Norway
Prior art keywords
pseudoephedrine
pharmaceutical compositions
compositions containing
new pharmaceutical
containing epinastine
Prior art date
Application number
NO20031537A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031537D0 (no
Inventor
Sara Abelaira
Daniel Bianchi
Francisco Gel
Victor Denker
Mabel Fernandez
Marta Cicconi De Vidal
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031537(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20031537D0 publication Critical patent/NO20031537D0/no
Publication of NO20031537L publication Critical patent/NO20031537L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20031537A 2000-10-06 2003-04-04 Nye farmasöytiske blandinger inneholdende epinastin og pseudoefedrin NO20031537L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00121828 2000-10-06
PCT/EP2001/011229 WO2002028373A1 (en) 2000-10-06 2001-09-28 New pharmaceutical compositions containing epinastine and pseudoephedrine

Publications (2)

Publication Number Publication Date
NO20031537D0 NO20031537D0 (no) 2003-04-04
NO20031537L true NO20031537L (no) 2003-06-04

Family

ID=8170029

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031537A NO20031537L (no) 2000-10-06 2003-04-04 Nye farmasöytiske blandinger inneholdende epinastin og pseudoefedrin

Country Status (32)

Country Link
EP (1) EP1326586B1 (pt)
JP (1) JP2004521864A (pt)
KR (1) KR20030036894A (pt)
CN (1) CN1291715C (pt)
AR (2) AR032479A1 (pt)
AT (1) ATE424813T1 (pt)
AU (2) AU2002212290B2 (pt)
BG (1) BG107686A (pt)
BR (1) BR0114339A (pt)
CA (1) CA2423288C (pt)
CZ (1) CZ2003945A3 (pt)
DE (1) DE60137952D1 (pt)
EA (1) EA007288B1 (pt)
EC (1) ECSP034513A (pt)
EE (1) EE200300138A (pt)
ES (1) ES2323570T3 (pt)
HK (1) HK1062196A1 (pt)
HR (1) HRP20030259A2 (pt)
HU (1) HUP0300970A3 (pt)
IL (1) IL154884A0 (pt)
ME (1) MEP39708A (pt)
MX (1) MXPA03002900A (pt)
MY (1) MY131159A (pt)
NO (1) NO20031537L (pt)
NZ (1) NZ525653A (pt)
PE (1) PE20020324A1 (pt)
PL (1) PL366123A1 (pt)
SK (1) SK4052003A3 (pt)
UA (1) UA75896C2 (pt)
WO (1) WO2002028373A1 (pt)
YU (1) YU24603A (pt)
ZA (1) ZA200302079B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1518448A (zh) * 2001-06-20 2004-08-04 ���鹫˾ 用于治疗鼻充血和鼻塞的抗组胺剂
JP4549618B2 (ja) * 2001-11-22 2010-09-22 第一三共ヘルスケア株式会社 鼻炎用組成物
WO2004014353A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
JP5021155B2 (ja) * 2003-08-01 2012-09-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物
EP1750717B1 (en) * 2004-02-11 2017-07-19 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
WO1999032125A1 (en) * 1997-12-23 1999-07-01 Schering Corporation Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
JP2002527381A (ja) * 1998-10-09 2002-08-27 シェーリング コーポレイション アレルギー性疾患を処置するための組成物および方法
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Also Published As

Publication number Publication date
AU2002212290B2 (en) 2006-08-03
ES2323570T3 (es) 2009-07-21
AR032479A1 (es) 2003-11-12
CA2423288A1 (en) 2002-04-11
HUP0300970A2 (hu) 2003-11-28
HUP0300970A3 (en) 2005-03-29
KR20030036894A (ko) 2003-05-09
CN1468094A (zh) 2004-01-14
IL154884A0 (en) 2003-10-31
MXPA03002900A (es) 2003-09-10
EP1326586B1 (en) 2009-03-11
BG107686A (bg) 2003-11-28
CA2423288C (en) 2007-11-13
CZ2003945A3 (cs) 2003-08-13
EA200300430A1 (ru) 2003-10-30
ZA200302079B (en) 2004-05-05
SK4052003A3 (en) 2003-09-11
MY131159A (en) 2007-07-31
BR0114339A (pt) 2003-12-09
AR087240A2 (es) 2014-03-12
JP2004521864A (ja) 2004-07-22
PE20020324A1 (es) 2002-06-18
WO2002028373A1 (en) 2002-04-11
ATE424813T1 (de) 2009-03-15
EP1326586A1 (en) 2003-07-16
DE60137952D1 (de) 2009-04-23
EA007288B1 (ru) 2006-08-25
AU1229002A (en) 2002-04-15
NO20031537D0 (no) 2003-04-04
YU24603A (sh) 2006-05-25
MEP39708A (en) 2011-02-10
HK1062196A1 (en) 2004-10-21
UA75896C2 (en) 2006-06-15
HRP20030259A2 (en) 2005-02-28
CN1291715C (zh) 2006-12-27
NZ525653A (en) 2006-07-28
ECSP034513A (es) 2003-04-25
EE200300138A (et) 2003-08-15
PL366123A1 (en) 2005-01-24

Similar Documents

Publication Publication Date Title
NO20031744L (no) Nye ikke-imadazolforbindelser og farmasöytisk preparat omfattende slike
NO20025450L (no) Ny farmasöytisk sammensetning
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
DK1263721T3 (da) Farmaceutiske sammensætninger, der indeholder 3-aminoazetidinderivater, nye derivater og fremstilling deraf
DE60134387D1 (de) Pseudoephedrin und fexofenadine enthaltende osmotische vorrichtung
NO20033002L (no) Nye kinuklidinderivater og medisinske sammensetninger inneholdende det samme
HUP0302893A3 (en) Non-imidazole aryloxypiperidines and pharmaceutical compositions containing them and their use
NO20000847D0 (no) Elastiske brønnsementsammensetninger og fremgangsmåter
NO20014135L (no) Nye sulfonamidforbindelser og deres anvendelse
FI20105657A (fi) Farmaseuttisia koostumuksia
NO20022334L (no) Ny sammensetning og anvendelse
ITMI20010748A0 (it) Composizioni farmaceutiche
DK1339292T3 (da) Sammensætning og fremgangsmåde
NO20025357L (no) Antranylamider og deres anvendelse som legemidler
ATE275938T1 (de) Stabiles und wirksames weiches feststoffprodukt
NO20035798L (no) Tablett som inneholder cetirizin og pseudoefedrin
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
NO20030822L (no) Nye forbindelser og fremgangsmåter
NO20025968L (no) Pyridin-2-yl-aminoalkylkarbonylglycyl-<beta>-alanin og derivater derav
NO20031537D0 (no) Nye farmasöytiske blandinger inneholdende epinastin og pseudoefedrin
DK1429770T3 (da) Nye formuleringer og anvendelse deraf
NO20032821D0 (no) Sea-trosy og beslektede fremgangsmåter
NO20014149D0 (no) Nye dipeptidforbindelser og deres anvendelse som medisiner
DK1112262T3 (da) Substituerede gamma-delta-lactamer og analoger deraf og anvendelser relateret dertil
NO20024299L (no) Ístrogen-regulert ukonvensjonelt myosin-relatert protein: sammensetninger og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application